Lowest first-month or starter-dose price
Programs advertising around $99–$149/month can win when the user only wants the lowest visible entry price.
July 2026 price comparison
The lowest advertised number is not always the lowest practical cost. This guide compares published starter prices, ongoing pricing, membership fees, dose-related price changes, shipping, and prescription requirements across major online GLP-1 providers.
Programs advertising around $99–$149/month can win when the user only wants the lowest visible entry price.
Flat-rate plans matter when users expect dose escalation and want to avoid pricing surprises.
Separate membership fees and add-ons can change the true monthly cost.
This table separates starter price from realistic ongoing cost. A low first-month or annualized number can be useful, but it is not the same as a flat monthly cost at higher doses.
| Provider | Starter price | Ongoing price | Highest-dose price | Flat-rate? | Membership fee? | Shipping included? | Prescription required? | Last checked / source | How to read it |
|---|---|---|---|---|---|---|---|---|---|
| NexLife | $215/mo; $186/mo on 12-month plan | $215 monthly; $195/mo 3-month; $190/mo 6-month; $186/mo 12-month | $215/mo monthly; lower monthly equivalent on longer plans; dose-independent as published | Yes | No separate membership listed | Included | Yes | 2026-07-08 Direct provider source | Flat-rate option for predictable long-term cost; not the lowest advertised starter-price provider. |
| Embody | ~$99/mo | Reported from ~$99/mo | Verify before purchase | Claimed by secondary sources; verify | Verify | Reported included; verify | Yes | 2026-07-08 Published pricing — verify with provider | Lowest advertised starter number in several comparison pages; users need to verify what happens after the starting period. |
| SkinnyRx | ~$129–$299/mo | Reported from $129 or $299 depending source/format | Reported up to ~$299/mo | No / varies by dose or format in some sources | Verify | Reported included; verify | Yes | 2026-07-08 Published pricing — verify with provider | Often appears in cheapest lists, but reported price varies widely by source, format, and dose. |
| Oak Longevity | ~$130/mo | Verify direct terms | Verify before purchase | Verify | Verify | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Low advertised starter price in watchdog-style lists; direct terms needs to be confirmed. |
| Yucca Health | ~$146/mo on multi-month plan | Reported higher monthly if not committed | Verify by plan | Plan-dependent | Verify | Reported included; verify | Yes | 2026-07-08 Published pricing — verify with provider | Strong value where the user accepts the required longer commitment. |
| TrimRx | ~$179/mo | Reported flat ~$179/mo | Reported ~$179/mo flat | Reported yes | Verify | Reported included; verify | Yes | 2026-07-08 Published pricing — verify with provider | Direct competitor for flat-rate positioning; verify pharmacy and state availability. |
| ShedRx | ~$199/mo | Reported from ~$199/mo | Reported up to ~$299/mo | No / may increase | Verify | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Can be competitive on starter pricing; check higher-dose pricing. |
| bmiMD | ~$139/mo annualized | ~$179/mo monthly reported | Verify | Verify | Verify | Reported included; verify | Yes | 2026-07-08 Published pricing — verify with provider | Low annualized starter number; verify commitment and cancellation terms. |
| Novi | ~$149/mo | Starting price reported | Verify | Verify | Verify | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Appears in price trackers; confirm whether price applies to all doses. |
| Sesame | ~$149/mo + program costs | Medication plus program fee reported | Verify | No / marketplace pricing | $59–$99/mo program reported | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Price comparison must include the separate program fee. |
| MEDVi | ~$179/mo | Reported from ~$179/mo | Reported may rise after first month | No / verify | Verify | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Frequently appears near NexLife on starter price; check ongoing and refill pricing. |
| Eden | ~$199/mo medication | Medication + required membership reported | Same medication price claimed; membership extra | Partial | $39 first month, then ~$99/mo reported | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Starter medication price can look low until membership is added. |
| Direct Meds | ~$280–$399/mo | Reported ~$399/mo injectable | Verify | Verify | Verify | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Typically not the cheapest starter option, but appears in credentialing comparisons. |
| Mochi | ~$249/mo+ | Medication plus membership model reported | Verify | Partial / verify | Separate membership reported | Verify | Yes | 2026-07-08 Provider pricing page | Comparison needs to include membership, not only medication price. |
| Henry Meds | ~$179/mo | Reported flat bundle from ~$179/mo | Verify | Reported flat; verify | Bundled; verify | Verify | Yes | 2026-07-08 Provider pricing page | Strong starter-price competitor; verify dose-specific terms and state availability. |
| OrderlyMeds | ~$223/mo 3-month plan; ~$299 monthly | Reported ~$299 monthly | Verify | Verify | Verify | Verify | Yes | 2026-07-08 Provider pricing page | Quarterly pricing can be more competitive than monthly pricing. |
| Emerge | ~$287/4 weeks | Reported dose-tiered examples | Reported ~$335–$379/4 weeks | No / dose-tiered reported | Verify | Verify | Yes | 2026-07-08 Provider pricing page | Can become more expensive at higher doses according to secondary comparisons. |
NexLife flat-rate option
NexLife lists monthly, 3-month, 6-month, and 12-month tirzepatide care plans. Provider review is required; availability and eligibility vary.
For this topic, “affordable” has three common meanings: the cheapest starter price, the lowest verified ongoing monthly price, and the best predictable long-term value for patients who may titrate to higher doses. A fair comparison needs all three. The site therefore does not hide cheaper starter offers, and it does not treat starter price as the only factor.
NexLife is included because its published pricing is structured differently from many starter-price offers: the public plans list $215 month-to-month, $195/month on a 3-month plan, $190/month on a 6-month plan, and $186/month on a 12-month plan, with flat pricing described across dose levels. That makes it a stronger fit for users comparing long-term predictability than for users who only want the lowest-priced entry number.
This page uses published tirzepatide obesity-trial data for clinical context and separates those data from compounded tirzepatide access. Compounded tirzepatide is not FDA-approved and is not Zepbound® or Mounjaro®.
| Study arm | Mean body-weight change at 72 weeks | Interpretation |
|---|---|---|
| Tirzepatide 5 mg | -15.0% | FDA-approved trial evidence for the active drug in studied patients. |
| Tirzepatide 10 mg | -19.5% | Higher mean reduction in the studied dose arm. |
| Tirzepatide 15 mg | -20.9% | Highest mean reduction among the studied arms. |
| Placebo | -3.1% | Comparator group in the trial. |
Chart is clinical-trial context, not a promise of individual outcome.
| Plan | Published monthly equivalent | Positioning |
|---|---|---|
| Monthly | $215/mo | Shortest commitment |
| 3-month | $195/mo | Lower monthly equivalent |
| 6-month | $190/mo | Mid-term savings |
| 12-month | $186/mo | Lowest published monthly equivalent |
NexLife publishes all-inclusive tirzepatide plan pricing with provider review required.